DTX-168-201 Study Site — Grand Rapids, Michigan

DTX-168-201 Study Site is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

DTX-168-201 Study Site has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Fuchs Endothelial Corneal Dystrophy, Fuchs.

Sponsors: Design Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for DTX-168-201 Study Site?

DTX-168-201 Study Site has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has DTX-168-201 Study Site conducted?

DTX-168-201 Study Site has 1 clinical trials on record, with 1 currently active. Their work covers Fuchs Endothelial Corneal Dystrophy, Fuchs.

Is DTX-168-201 Study Site accredited by Crixeo Health?

DTX-168-201 Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about DTX-168-201 Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.